UB
Umakrishna Bandaru
About Umakrishna Bandaru
Umakrishna Bandaru has 11 years in corporate governance. Holds Designated Partner and Additional Director roles. Currently with 2 companies, including Oxydrive Llp and Plus Healthcare Solutions Private Limited. Formerly with 1 company, such as Fibonacci Automation Consultancy Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Oxydrive Llp
AAX-9666
|
Designated Partner | 28 Jul 2021 | 2021 | Active |
|
Plus Healthcare Solutions Private Limited
U52100TG2012PTC080783
|
Additional Director | 03 Jun 2025 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Fibonacci Automation Consultancy Private Limited
U72200TG2015PTC098614
|
Director | 23 Apr 2015 | 2015 | Under Process Of Striking Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umakrishna Bandaru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umakrishna Bandaru
Umakrishna Bandaru has 11 years in corporate governance. Holds Designated Partner and Additional Director roles. Currently with 2 companies, including Oxydrive Llp and Plus Healthcare Solutions Private Limited. Formerly with 1 company, such as Fibonacci Automation Consultancy Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Umakrishna Bandaru is associated with 2 companies as Designated Partner and Additional Director.
Umakrishna Bandaru has expertise in General Business, Healthcare.
Umakrishna Bandaru has 11 years in corporate governance.